scispace - formally typeset
M

Meridith Blevins

Researcher at Vanderbilt University

Publications -  77
Citations -  1982

Meridith Blevins is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 26, co-authored 77 publications receiving 1727 citations. Previous affiliations of Meridith Blevins include Vanderbilt University Medical Center.

Papers
More filters
Journal ArticleDOI

Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambézia, Mozambique

TL;DR: Three of four HIV-infected women in rural Mozambique did not bring their children for early infant HIV diagnosis and maternal receipt of antiretroviral therapy has favorable implications for maternal health that will increase the likelihood of early infant diagnosis.
Journal ArticleDOI

Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial

TL;DR: This integrated, family-focused PMTCT service package improved maternal ART initiation and mother and infant retention in care and will positively affect global goals for the elimination of mother-to-child HIV transmission.
Journal ArticleDOI

Engagement of Men in Antenatal Care Services: Increased HIV Testing and Treatment Uptake in a Community Participatory Action Program in Mozambique

TL;DR: A new type of male-to-male community health agent, “Male Champions”, was trained who focused on counseling male partners to create new, male-friendly community norms around engagement in spousal/partner pregnancies to increase testing and treatment acceptability during pregnancy.
Journal ArticleDOI

Impact of definitions of loss to follow-up on estimates of retention disease progression and mortality: application to an HIV program in Mozambique.

TL;DR: In a cohort of 9,692 HIV-infected patients initiating antiretroviral therapy in Mozambique from 2006 to 2011, it is found that rates of LTF 2 years after treatment initiation were high and varied substantially, from 22% to 84% depending on the LTF definition used.